Molecular basics on Genitourinary Malignancies.- Clinical Aspects and Investigations.-Radiological Investigations in Genitourinary Cancer.- New Imaging Modalities.- Principles of systemic therapy in urologic tumors.- The Emerging Role of immunotherapy in GU-tumors.- Bone targeted therapy.- Clinical Emergencies in Genitourinary Cancers.- Nuclear Medicine in Urological Cancer.- Strategies addressing quality of life: Patient reported outcome and symptoms management.- Pain control in genitourinary cancer patients.- Clinical trials and their principles.- GU malignancies: Prostate Cancer.- Bladder Cancer.- Renal Cancer.- Testicular Cancer.- Penile Cancer.- Other Rare Urologic Malignancies. - Diet and Genitourinary Cancer.- Systemic genitourinary Oncology.
Prof. Dr. med. Axel Merseburger is Professor of Urology and
Chairman of the Department of Urology at University Hospital
Schleswig‑Holstein, Campus Lübeck, Germany. After graduating from
Hannover Medical School in 2002, he carried out a residency in
surgery and urology at the Eberhard Karls University, in Tübingen,
followed by a research fellowship at the Miller School of Medicine,
Miami, USA (2006). He became Associate Professor in 2009 and full
Professor in 2012 at Hannover Medical School.Professor Merseburger
is a member of various uro-oncology organisations and serves as an
advisor for the European Association of Urology (EAU) Guideline
Group for Renal Cancer and was the Chairman of the EAU Guideline
Group for Lasers and Technologies. He acts as reviewer and
editorial board member for several urology and oncology indexed
journals and is associate editor of the World Journal of Urology
and editor in Chief of European Oncology & Haematology
Journal.Professor Merseburger’s research activity encompasses both
molecular and clinical aspects of uro-oncology, with specific
interest in biomarkers and prognostic factors for prostate cancer,
renal cell carcinoma and transitional cell carcinoma. He has
authored and co-authored more than 200 peer-reviewed articles and
he is the principal investigator in multiple phase II and III
clinical trials.
Prof. Dr. med. Maximilian Burger, F.E.B.U.,MD, is Professor
of Urology and Chairman of the Department of Urology, Caritas-St.
Josef Medical Center, University of Regensburg, Germany. He was
born in Munich, Germany in 1974 and attended the Medical Schools of
the Universities of Ulm and Regensburg and Tulane University, New
Orleans, Louisiana, USA graduating in 2000. He underwent urology
training at the departments of the Universities of Mainz and
Regensburg and was board certified in 2005. In 2007 he was
appointed Assistant Professor ofUrology by the University of
Regensburg. From 2011 to 2013 he was appointed Assistant Professor
of Urology by the Julius-Maximilians University of Würzburg
(Chairman Prof. Dr. Riedmiller) serving as Deputy Chairman
(Leitender Oberarzt). He was appointed Professor of Urology and
Chairman of the department in Regensburg in 2013. His main clinical
and academical focus is surgical and medical uro-oncology. He has
authored and coauthored numerous papers mainly on bladder and
prostate cancer. He is a member of the national German bladder
cancer guideline panel (S3) since 2012 and a member of the
non-muscle invasive bladder cancer guideline panel of the European
Association of Urology (EAU) since 2012 serving as its
Vice-Chairman. In 2014, he was elected to the board of the the
German Association of Urology (DGU).
Ask a Question About this Product More... |